Global Coronary Stents Market 2017-2021




$ 3500

In Stock

About Coronary Stents

Coronary artery disease (CAD) or atherosclerotic heart disease is a type of heart disease that is associated with the hardening of the arteries due to the accumulation of fatty compounds, cholesterol, calcium, and other blood clotting materials in and around the artery wall. These lesions, if become unstable or clinically significant, are treated with PCI, which require balloon angioplasty and stent implantation. Coronary stents or cardiac stents are small, expandable tube-shaped devices made of stainless steel, which are placed in the artery for easy blood flow during the treatment of CAD.

Technavios analysts forecast the global coronary stents market to grow at a CAGR of 5.61% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global coronary stents market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of coronary stents.

The market is divided into the following segments based on geography:

Technavio's report, Global Coronary Stents Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Abbott Laboratories
Boston Scientific

Other prominent vendors
Shandong JW Medical Systems
Biosensors International Group
Opto Circuits
Cook Medical
Elixir Medical
Envision Scientific
Meril Life Sciences

Market driver
Increasing prevalence of cardiovascular disease (CVD) and government initiatives
For a full, detailed list, view our report

Market challenge
Stringent regulations for device approval
For a full, detailed list, view our report

Market trend
Emergence of digital catheterization laboratories in hospitals
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.

Find more reports on related topics -

Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
Key market highlights
PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 06: Market segmentation by products
Bioresorbable stents
PART 07: Market segmentation by end-user
Physicians' offices
PART 08: Geographical segmentation
Coronary stents market in Americas
Coronary stents market in EMEA
Coronary stents market in APAC
PART 09: Decision framework
PART 10: Drivers and challenges
Market drivers
Impact of drivers on key customer segments
Market challenges
Impact of challenges on key customer segments
PART 11: Market trends
Growing adoption of hybrid procedure
Increasing partnerships and collaboration activities
Emergence of digital catheterization laboratories in hospitals
PART 12: Vendor landscape
Competitive landscape analysis
PART 13: Key vendor analysis
Abbott Laboratories
Boston Scientific
Key companies to watch
Other prominent vendors
PART 14: Appendix
List of abbreviations
List of Exhibits
Exhibit 01: Global coronary stents market: Impact assessment
Exhibit 02: Scope of coronary stents based on geography 2017-2021
Exhibit 03: Global coronary stents market 2016-2021 ($ billions)
Exhibit 04: Five forces analysis
Exhibit 05: Global coronary stents market revenue by product in 2016-2021 ($ billions)
Exhibit 06: Market overview: DES
Exhibit 07: Global DES market 2016-2021 ($ billions)
Exhibit 08: Clinical studies: Comparison between DES and BMS
Exhibit 09: Market overview: Bioresorbable stents
Exhibit 10: Global bioresorbable stents market 2016-2021 ($ billions)
Exhibit 11: Clinical research on bioresorbable vascular scaffold by Abbott Laboratories
Exhibit 12: Clinical study: Bioresorbable stents compared with DES
Exhibit 13: Market overview: BMS
Exhibit 14: Global BMS market 2016-2021 ($ billions)
Exhibit 15: Global coronary stents market by end-users 2016
Exhibit 16: Reimbursement comparison for ASCs, hospital outpatient departments, and physicians' offices in US
Exhibit 17: Global coronary stents market by geography 2016-2021 ($ billions)
Exhibit 18: Coronary stents market in Americas 2016-2021 ($ billions)
Exhibit 19: Coronary stents market in Americas: Country-specific market analysis
Exhibit 20: Number of revascularization procedures in EMEA 2006 and 2013
Exhibit 21: Coronary stents market in EMEA 2016-2021 ($ billions)
Exhibit 22: Coronary stents market in EMEA: Country-specific market analysis
Exhibit 23: Coronary stents market in APAC 2016-2021 ($ billions)
Exhibit 24: Coronary stents market in APAC: Country-specific market analysis
Exhibit 25: Impact of drivers
Exhibit 26: Coronary stenting procedure: Cost components and prices
Exhibit 27: Impact of challenges
Exhibit 28: Clinical study for hybrid procedure
Exhibit 29: Market impact analysis: Mergers and acquisitions (M&A) and collaboration activities
Exhibit 30: Competitive structure analysis of global coronary stents market
Exhibit 31: Competitive landscape of global coronary stents market 2016
Exhibit 32: Strategies of large and small companies in global coronary stents market
Exhibit 33: Abbott Laboratories: Products
Exhibit 34: Abbott Laboratories: Key highlights
Exhibit 35: Abbott Laboratories: Strength assessment
Exhibit 36: Abbott Laboratories: Strategy assessment
Exhibit 37: Abbott Laboratories: Opportunity assessment
Exhibit 38: Boston Scientific: Products
Exhibit 39: Boston Scientific: Key highlights
Exhibit 40: Boston Scientific: Strength assessment
Exhibit 41: Boston Scientific: Strategy assessment
Exhibit 42: Boston Scientific: Opportunity assessment
Exhibit 43: Medtronic: Products
Exhibit 44: Medtronic: Key highlights
Exhibit 45: Medtronic: Strength assessment
Exhibit 46: Medtronic: Strategy assessment
Exhibit 47: Medtronic: Opportunity assessment